Bit & Bridle

Equine Motor Neuron Disease (EMND)

Equine Motor Neuron Disease (EMND) is a progressive, degenerative neurological condition caused by a deficiency of vitamin E (alpha-tocopherol) that results in oxidative damage to the motor neurons of the spinal cord and brainstem. Affected horses develop a characteristic clinical syndrome of muscle wasting, generalised weakness, and an unusual stance in which they constantly shift their weight from leg to leg. EMND is not contagious and is not inherited, but it is entirely preventable through adequate vitamin E nutrition. First formally described in 1990, it is now recognised as one of the most important nutritional-neurological diseases of horses.

Other Names

  • EMND
  • Equine neurodegenerative disease
  • Equine lower motor neuron disease

What Is Equine Motor Neuron Disease?

EMND is caused by chronic vitamin E deficiency leading to oxidative damage of motor neuron cell bodies — specifically the ventral horn cells of the spinal cord and cranial motor nuclei of the brainstem. Vitamin E is the primary fat-soluble antioxidant in the equine nervous system. When levels fall below a critical threshold for a prolonged period (typically at least 18 months of deficiency), lipid peroxidation damages the lipid-rich membranes of motor neuron axons, leading to axonal degeneration and ultimately neuronal death.

The disease has similarities to Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's disease) in humans, in that it involves selective degeneration of lower motor neurons. However, EMND is nutritional rather than genetic in origin and is reversible in its early stages if vitamin E supplementation is started promptly.

Causes

The underlying cause is consistently a prolonged deficiency of vitamin E in the diet. Fresh pasture grass is by far the richest natural source of alpha-tocopherol for horses. When horses are deprived of access to fresh grass for extended periods — typically 18 months or more — serum vitamin E levels drop to concentrations insufficient to protect motor neurons from oxidative damage.

Risk factors include:

  • Prolonged stabling with no access to fresh grass
  • Feeding solely preserved forages (hay, haylage, silage) — vitamin E content drops significantly during preservation
  • Diets based on grain and hay without vitamin E supplementation
  • Competition horses on restricted turnout
  • Horses in drought-affected areas with poor pasture quality
  • Fat malabsorption conditions — vitamin E is fat-soluble and requires dietary fat for absorption

Most affected horses have been stabled for extended periods with no pasture access and have been fed hay-based diets without adequate vitamin E supplementation. There is no breed, sex, or age predisposition, though the disease has been reported most commonly in adult horses over 3 years of age.

Symptoms and Signs

EMND has a characteristic clinical presentation that experienced vets can often recognise immediately. Signs include:

  • Weight loss with generalised muscle wasting, despite often maintaining a reasonable appetite
  • Abnormal stance — horses stand with all four limbs tucked under the body, constantly shifting weight (a so-called "camped-under" posture)
  • Muscle fasciculations (fine twitching), particularly visible over the flank and hindquarters
  • Excessive lying down — affected horses spend significantly more time recumbent than normal
  • Weakness — horses may tremble when asked to move and tire rapidly
  • Abnormal sweating
  • Low head carriage
  • Dysphagia in advanced cases affecting cranial motor neurons
  • Fundic (retinal) pigmentary changes — a specific finding of brown mottled pigmentation of the retina, visible on ophthalmoscopic examination, is pathognomonic of EMND

There are two disease courses: an acute-subacute presentation where signs progress rapidly over weeks, and a chronic form where gradual deterioration occurs over months. In some horses, signs stabilise or partially improve after supplementation begins, particularly if the disease is caught early.

Diagnosis

Diagnosis is based on clinical signs, dietary history, and laboratory findings:

  • Serum vitamin E (alpha-tocopherol) measurement: Consistently low — typically below 1.5 µg/mL (normal > 2.0 µg/mL in most laboratories). This is an essential diagnostic test.
  • Ophthalmoscopy: The finding of characteristic brown retinal pigmentary changes (lipofuscin deposits) is highly specific to EMND and strongly supports the diagnosis
  • Muscle biopsy: Sacrocaudalis dorsalis medialis muscle biopsy shows characteristic neurogenic atrophy pattern — small angular atrophic fibres affecting both Type I and Type II muscle fibre types
  • Electromyography (EMG): May demonstrate denervation potentials in affected muscles
  • Serum CK and AST: Often mildly to moderately elevated due to muscle damage
  • Dietary assessment: A thorough review of the horse's feeding history over the preceding 1–2 years is essential

Treatment

The cornerstone of treatment is vitamin E supplementation, initiated as early as possible:

  • Natural vitamin E (d-alpha-tocopherol): Preferred over synthetic dl-alpha-tocopherol — significantly better bioavailability in horses. A typical therapeutic dose is 5,000–10,000 IU/day of natural vitamin E, given orally. Water-dispersible or powder formulations are absorbed more readily than oil-based capsules in horses.
  • Pasture access: Restoration of grazing on fresh green grass is highly beneficial and rapidly raises serum vitamin E levels
  • Supportive care: Ensure excellent nutrition, comfortable deep bedding to encourage normal resting behaviour, and minimal stress
  • Selenium status: Evaluate selenium levels — selenium and vitamin E work synergistically as antioxidants. Do not supplement selenium without measuring blood levels first, as toxicity is a risk.

Response to treatment is variable. Horses in the early stages of disease with mild signs may stabilise or show genuine improvement over weeks to months. Those with advanced disease and severe neuronal loss are unlikely to recover significantly, though their quality of life may be maintained.

Prevention

EMND is entirely preventable:

  • Provide regular access to fresh pasture — this is the most effective and natural source of vitamin E for horses
  • If stabling long-term, supplement with natural vitamin E at maintenance doses (1,000–2,000 IU/day for an adult horse — your vet may recommend higher for stabled horses)
  • Use commercially formulated feeds that include adequate vitamin E, particularly for horses on restricted turnout
  • Be aware that hay loses up to 60–80% of its vitamin E content compared to fresh grass — feeding hay as the sole forage always requires supplementation
  • Monitor serum vitamin E levels annually in horses that are stabled for prolonged periods

Prognosis

Prognosis depends on the severity of neuronal loss at the time of diagnosis. Approximately 40% of horses diagnosed with EMND show significant clinical improvement with vitamin E therapy. Around 40% stabilise without marked worsening but do not return to full athletic function. Approximately 20% continue to deteriorate despite treatment and require euthanasia. The key prognostic factor is the degree of irreversible neuronal loss — nerve cells cannot regenerate once destroyed.

When to Call the Vet

Contact your vet if your horse shows:

  • Unexplained, progressive muscle wasting despite normal appetite
  • Unusual stance with limbs tucked under and constant weight shifting
  • Excessive time spent lying down
  • Generalised weakness or trembling
  • A history of prolonged stabling with limited pasture access

Early diagnosis and prompt supplementation give the best chance of limiting neurological damage. For related conditions, see Equine Leukoencephalomalacia (ELEM) and Equine Night Blindness (CSNB). You may also find our guide to equine nutrition useful for understanding how dietary management influences neurological health.

Frequently Asked Questions

How long does vitamin E deficiency have to persist before EMND develops?

Studies suggest that sustained deficiency of 18 months or more is typically required before clinical signs of EMND develop. However, the exact threshold varies between individuals. Some horses may show clinical signs sooner if deficiency is severe; others with borderline low levels may not develop clinical disease. This is why annual monitoring of vitamin E levels in stabled horses is recommended.

Is EMND the same as Equine Degenerative Myeloencephalopathy (EDM)?

They are closely related but distinct conditions. Both are associated with vitamin E deficiency and involve spinal cord degeneration. However, EDM primarily affects proprioceptive tracts and presents with ataxia (incoordination) rather than the prominent muscle wasting and lower motor neuron signs of EMND. EDM also tends to affect young horses and may have an additional genetic susceptibility component. A horse may occasionally show features of both conditions.

Which form of vitamin E is best for horses?

Natural vitamin E (d-alpha-tocopherol) has significantly better bioavailability in horses than synthetic vitamin E (dl-alpha-tocopherol). Water-dispersible powder or liquid formulations are absorbed more effectively than oil-based capsules. Look for products specifically formulated for horses and confirmed to contain the natural form. Your vet can advise on appropriate dosing based on your horse's serum levels.

Can a horse with EMND be ridden?

Not during the acute phase or while the horse shows significant weakness, incoordination, or rapid fatigue. Riding a horse with active EMND poses a genuine safety risk. As signs stabilise with treatment, some horses with mild disease may eventually return to light work under veterinary guidance, but this must be assessed individually and monitored carefully.